Showing 1 - 20 results of 25 for search 'Gábor Mezo', query time: 0.05s
Refine Results
-
1
Overcharging Effect in Electrospray Ionization Mass Spectra of Daunomycin-Tuftsin Bioconjugates by Lilla Pethő, Gábor Mező, Gitta Schlosser
Published 2019-08-01
Article -
2
Influence of the Drug Position on Bioactivity in Angiopep-2—Daunomycin Conjugates by Lilla Pethő, Rita Oláh-Szabó, Gábor Mező
Published 2023-02-01
Article -
3
-
4
NGR-peptide-drug conjugates with dual targeting properties. by Kata Nóra Enyedi, Szilárd Tóth, Gergely Szakács, Gábor Mező
Published 2017-01-01
Article -
5
Photoinduced Hydrogel-Forming Caged Peptides with Improved Solubility by Kata N. Enyedi, Bettina Basa, Gábor Mező, Eszter Lajkó
Published 2024-01-01
Article -
6
-
7
NGR-Based Radiopharmaceuticals for Angiogenesis Imaging: A Preclinical Review by György Trencsényi, Kata Nóra Enyedi, Gábor Mező, Gábor Halmos, Zita Képes
Published 2023-08-01
Article -
8
-
9
-
10
Redesigning of Cell-Penetrating Peptides to Improve Their Efficacy as a Drug Delivery System by Ildikó Szabó, Mo’ath Yousef, Dóra Soltész, Csaba Bató, Gábor Mező, Zoltán Bánóczi
Published 2022-04-01
Article -
11
Optimizing the enzymatic release of MMAE from isoDGR-based small molecule drug conjugate by incorporation of a GPLG-PABC enzymatically cleavable linker by Marco Zambra, Ivan Ranđelović, Francesco Talarico, Adina Borbély, Laura Svajda, Laura Svajda, József Tóvári, Gábor Mező, Gábor Mező, Lizeth Bodero, Sveva Colombo, Sveva Colombo, Federico Arrigoni, Elettra Fasola, Silvia Gazzola, Umberto Piarulli
Published 2023-07-01
Article -
12
-
13
Characterisation of the cell and molecular biological effect of peptide-based daunorubicin conjugates developed for targeting pancreatic adenocarcinoma (PANC-1) cell line by Zsófia Szász, Kata Nóra Enyedi, Angéla Takács, Nóra Fekete, Gábor Mező, László Kőhidai, Eszter Lajkó
Published 2024-04-01
Article -
14
Comparative cell biological study of in vitro antitumor and antimetastatic activity on melanoma cells of GnRH-III-containing conjugates modified with short-chain fatty acids by Eszter Lajkó, Sarah Spring, Rózsa Hegedüs, Beáta Biri-Kovács, Sven Ingebrandt, Gábor Mező, László Kőhidai
Published 2018-09-01
Article -
15
Protein expression profile of HT-29 human colon cancer cells after treatment with a cytotoxic daunorubicin-GnRH-III derivative bioconjugate. by Verena Natalie Schreier, Lilla Pethő, Erika Orbán, Andreas Marquardt, Brindusa Alina Petre, Gábor Mező, Marilena Manea
Published 2014-01-01
Article -
16
Drug targeting to decrease cardiotoxicity – determination of the cytotoxic effect of GnRH-based conjugates containing doxorubicin, daunorubicin and methotrexate on human cardiomyoc... by Livia Polgár, Eszter Lajkó, Pál Soós, Orsolya Láng, Marilena Manea, Béla Merkely, Gábor Mező, László Kőhidai
Published 2018-06-01
Article -
17
-
18
-
19
-
20
Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy: Development of Bombesin-Based Peptide–Drug Conjugates by Jacopo Gomena, Balázs Vári, Rita Oláh-Szabó, Beáta Biri-Kovács, Szilvia Bősze, Adina Borbély, Ádám Soós, Ivan Ranđelović, József Tóvári, Gábor Mező
Published 2023-02-01
Article